Syndax Pharmaceuticals (SNDX) PT Lowered to $37 at UBS
Tweet
Share
E-mailGet Alerts SNDX Hot Sheet
Price: $21.82 +4.45%
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
UBS analyst David Dai lowered the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $37.00 (from $38.00) while maintaining a Buy rating.
You May Also Be Interested In
- Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- TransAlta (TA:CN) (TAC) PT Raised to Cdn$19 at Desjardins
- EQB Inc (EQB:CN) (EQGPF) PT Raised to Cdn$151 at CIBC
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
